Tadalafil and acetazolamide versus acetazolamide for the prevention of severe high-altitude illness

Journal of Travel Medicine

Volumn 19, Issue 5, 2012, Pages 308-310

  Leshem, Eyal ^a   Caine, Yehezkel ^b   Rosenberg, Elliot ^c   Maaravi, Yoram ^d   Hermesh, Hagai ^e   Schwartz, Eli ^a  

^a SHEBA MEDICAL CENTER   (Israel)

^b HERZOG HOSPITAL   (Israel)

^c MINISTRY OF HEALTH   (Israel)

^d HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^e GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; TADALAFIL; UNCLASSIFIED DRUG; URAMOX;

ADULT; ALTITUDE DISEASE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE;

ACETAZOLAMIDE; ACUTE DISEASE; ADULT; ALTITUDE SICKNESS; CARBOLINES; CARBONIC ANHYDRASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEADACHE; HUMANS; HYPERTENSION, PULMONARY; MALE; MOUNTAINEERING; SEVERITY OF ILLNESS INDEX; TANZANIA; YOUNG ADULT;

EID: 84865849216     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2012.00636.x     Document Type: Article

References (10)

1. Shah NM, Windsor JS, Meijer H, Hillebrandt D,. Are UK commercial expeditions complying with wilderness medical society guidelines on ascent rates to altitude? J Travel Med 2011; 18: 214-216.
2. Maggiorini M, Brunner-La Rocca HP, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006; 145: 497-506. (Pubitemid 46780953)
3. Davies AJ, Kalson NS, Stokes S, et al. Determinants of summiting success and acute mountain sickness on Mt Kilimanjaro (5895 m). Wilderness Environ Med 2009; 20: 311-317.
4. Hauser M, Mueller A, Swai B, et al. Deaths due to high altitude illness among tourists climbing Mt Kilimanjaro. Proceedings of the 2004 South African Travel Medicine Society; 2004; Cape Town, South Africa.
5. Karinen H, Peltonen J, Tikkanen H,. Prevalence of acute mountain sickness among Finnish trekkers on Mount Kilimanjaro, Tanzania: an observational study. High Alt Med Biol 2008; 9: 301-306.
6. Moore K, Vizzard N, Coleman C, et al. Extreme altitude mountaineering and type 1 diabetes; the diabetes federation of Ireland Kilimanjaro expedition. Diabet Med 2001; 18: 749-755. (Pubitemid 32955528)
7. Roach JM, Bartsch P, Olez O, Hackett PH,. The Lake Louise acute mountain sickness scoring system. In:, Sutton JR, Houston CS, Coates G, eds. Hypoxia and molecular medicine. Burlington: Queen City Press, 1993: 272-274.
8. Leshem E, Pandey P, Shlim DR, et al. Clinical features of patients with severe altitude illness in Nepal. J Travel Med 2008; 15: 315-322.
9. Van Osta A, Moraine JJ, Melot C, et al. Effects of high altitude exposure on cerebral hemodynamics in normal subjects. Stroke 2005; 36: 557-560. (Pubitemid 40344156)
10. Anholm JD, Milne EN, Stark P, et al. Radiographic evidence of interstitial pulmonary edema after exercise at altitude. J Appl Physiol 1999; 86: 503-509. (Pubitemid 29075800)